Skip to main content
Signal8

Choo Chee Kong

SEC insider (Form 3/4/5 filer). CIK 0001970632. Director & 10% Owner at CytoMed Therapeutics Ltd (GDTC). 3 reported Form 4/5 transactions since Sep 2024; latest on Jul 20, 2026. Located in SINGAPORE.

Companies Choo Chee Kong has filed insider reports for

  • CytoMed Therapeutics Ltd (GDTC): Director, 10% Owner
Choo Chee Kong profile photo

Choo Chee Kong

CIK: 0001970632

Transaction Breakdown

Open Market Buys (P)3 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CytoMed Therapeutics Ltd logo
GDTC

CytoMed Therapeutics Ltd

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • CytoMed Therapeutics Ltd logo
    GDTC

    CytoMed Therapeutics Ltd

    Jul 20, 2026
    Purchase
    Direct
    100K shares at avg. $1.50$150K
  • CytoMed Therapeutics Ltd logo
    GDTC

    CytoMed Therapeutics Ltd

    Jul 14, 2026
    Purchase
    Direct
    100K shares at avg. $1.50$150K
  • CytoMed Therapeutics Ltd logo
    GDTC

    CytoMed Therapeutics Ltd

    May 13, 2026
    Purchase
    Direct
    112K shares at avg. $1.15$129K

1-3 of 3